Drug Information

Drug General Information
Drug ID
D0I3EI
Former ID
DIB010893
Drug Name
NK-1001
Synonyms
NNYK-1001; NYK-1001
Drug Type
Small molecular drug
Indication Atrial fibrillation [ICD9: 272, 427.31; ICD10:E78, I48] Discontinued in Phase 2 [549188]
Company
Nyken BV
Structure
Download
2D MOL

3D MOL
Formula
C18H35N3O12
Canonical SMILES
C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)O)O)OC3C(C(C(C(O3)CN<br />)O)O)O)N
InChI
1S/C18H35N3O12/c19-2-6-8(23)10(25)12(27)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)11(26)9(24)7(3-22)31-18/h4-18,22-29H,1-3,19-21H2/t4-,5+,6-,7-,8-,9-,10+,11+,12-,13-,14-,15+,16-,17-,18-/m1/s1
InChIKey
NZCOZAMBHLSNDW-GUKOCFKPSA-N
PubChem Compound ID
3040841
PubChem Substance ID
36108322, 49871102, 50540011, 111652643, 135142479
Target and Pathway
Target(s) Heat shock protein 70 Target Info Modulator [532907]
Heat shock protein 27 Target Info Modulator [532907]
References
Ref 549188Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033456)
Ref 532907Novel therapeutic targets in the management of atrial fibrillation. Am J Cardiovasc Drugs. 2014 Dec;14(6):403-21.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.